Osteopathic Manipulative Therapy for Long COVID Symptoms
This study is looking at how Osteopathic Manipulative Therapy (OMT) might help people with Long COVID (also known as Post-Acute Sequelae of COVID-19 or PASC). OMT is a hands-on treatment that can help with body pain and movement. Researchers want to see if a specific OMT protocol, which previously helped with smell loss in Long COVID, can also improve other Long COVID symptoms. They also want to know if two OMT treatments are more effective than one. You might be able to join if you are 18 or older, have had a positive COVID-19 test at least 6 weeks ago, and are still experiencing at least one Long COVID symptom that affects your daily life. The study will measure symptom improvement using a survey called The Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC). The study is currently unclear on its recruitment status and plans to enroll 20 participants.
- Study design
- This interventional study plans to enroll 20 participants. It will compare a specific Long-COVID OMT protocol to a different OMT protocol.
- What's involved
- Participants will complete a digital survey and receive an OMT treatment in Week 1. In Week 2, they will complete another digital survey and receive the Long-COVID OMT treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will complete surveys at Week 1, Week 2, Week 3, and a final survey at Week 8 after enrollment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
At a glance
Conditions
NCT06883513
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Louisville Outpatient Care Center
Louisville, Kentuckystudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Darryl Kaelin, MD, Medical Doctorate (US) · PRINCIPAL_INVESTIGATOR · University of Louisville School of Medicine Chair of PM&R Division of the Department of Neurological Surgery
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC)On arrival for baseline before any treatment (week 1). On arrival for 2nd treatment (week 2). 7 days after 2nd treatment (week 3). Final Survey on week 8 of post-enrollment
The Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC) is a validated tool generated to assess for Long-COVID symptom burden generated by the University of Birmingham in the UK. The SBQ™-LC assesses 123 different symptoms of Long COVID. All items use the recall period "In the last 7 days..." and are scored according to one of the following: 1. symptom presence (Yes/No); 2. symptom frequency (0 = Never to 3 = Always); 3. symptom severity (0 = None to 3 = Severe); 4. or Interference in daily life (0 = Not at all to 3 = Severely). The SBQ™-LC has a Flesch-Kincaid Reading Grade level score of 5.33 suggesting it would be understood by a person with a 6th grade reading level according to the American education system. The SBQ™-LC's SMOG Index score of 8.27 means it should be understood by 93% of UK adults.(8-10) Higher scores suggest worsening symptom severity. Maximum raw score depends on which independent scale within the tool is measured. Ranges from 5-38 depending